GHK Basic 50 mg

Technical Details

Dosage & Usage Guidelines

GHK Basic 50 mg is commonly used in experimental models focused on:

• Wound healing and tissue regeneration
• Anti-aging and skin tightening effects
• Post-surgical skin recovery
• Hair follicle stimulation and growth support
• Antioxidant and anti-inflammatory modulation

In cosmetic and dermatological research protocols, GHK is often compared or combined with B7-33 for anti-fibrotic properties or Cartalax to explore musculoskeletal repair in aging models.

Suggested Experimental Use

• Dosage: 1–5 mg daily (varies by study)
• Administration: Subcutaneous or intradermal
• Cycle Duration: 10–30 days in regenerative models

Stacking Options

GHK Basic can be stacked in synergistic research protocols with:

• DSIP – for improving sleep recovery and hormonal balance
• Chonluten – for immune or lung recovery support
• FOX04-DRI – for anti-aging/senescence-clearing protocols
• AOD 9604 – to promote localized fat metabolism and recovery

Safety & Legal Status

GHK Basic is considered safe in preclinical settings and exhibits no hormonal, androgenic, or hepatotoxic effects. It does not aromatize, increase blood pressure, or cause systemic side effects. Like all Peptide Hubs products, it is intended for research use only and is not approved by the FDA for human consumption. See updates on regenerative peptide trials on ClinicalTrials.gov.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions